Phase 2 study of veliparib and local irradiation, followed by maintenance veliparib and temozolomide, in patients with newly diagnosed highgrade glioma without H3 K27M or BRAF Mutations: A report from the Children's Oncology Group ACNS1721 study Meeting Abstract

  

Authors:	Karajannis, M.; Onar-Thomas, A.; Baxter, P.; Butingan, N.; Fuller, C.; Gajjar, A.; Haque, S.; Jabado, N.; Lin, T.; Lucas, J.; MacDonald, S.; Matsushima, C.; Patel, N.; Pierson, C.; Springer, L.; Stark, E.; Souweidane, M.; Walsh, M.; Zaky, W.; Fouladi, M.; Cohen, K.
Abstract Title:	Phase 2 study of veliparib and local irradiation, followed by maintenance veliparib and temozolomide, in patients with newly diagnosed highgrade glioma without H3 K27M or BRAF Mutations: A report from the Children's Oncology Group ACNS1721 study
Meeting Title:	20th International Symposium on Pediatric Neuro-Oncology (ISPNO 2022)
Journal Title:	Neuro-Oncology
Volume:	24
Issue:	Suppl. 1
Meeting Dates:	2022 Jun 12-15
Meeting Location:	Hamburg, Germany
ISSN:	1522-8517
Publisher:	Oxford University Press
Date Published:	2022-06-01
Start Page:	i60
End Page:	i61
Language:	English
ACCESSION:	WOS:000840122400225
PROVIDER:	wos
DOI:	10.1093/neuonc/noac079.222
Notes:	Meeting Abstract: HGG-06 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/198991